Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

News Daily News

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Yael L. Maxwell

August 17, 2018

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Daily News

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Yael L. Maxwell

July 17, 2015

News Daily News

Statement on LAA Closure Highlights Key Issues for Growing Field

July 02, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

News Daily News

Study Documents Complications of LAA Closure With the Lariat Device

May 05, 2015

News Daily News

After Years of Scrutiny, Watchman Ready for Prime Time

April 03, 2015

News Daily News

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

Todd Neale

February 17, 2015

News Daily News

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Yael L. Maxwell

November 06, 2014

News Daily News

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

L.A. McKeown

October 16, 2014

News Conference News TCT 2014

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

September 14, 2014

News Daily News

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

Yael L. Maxwell

August 07, 2014

News Daily News

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

July 03, 2014

News Daily News

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

Yael L. Maxwell

June 07, 2013

News Daily News

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

Yael L. Maxwell

May 17, 2013

News Daily News

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Yael L. Maxwell

April 12, 2013

Advertisement

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Novel LAA Closure Device Shows Promise in Early Experience

‘The Bleeding Edge’ Documentary, Tackling Medical Device Regulation, Spurs Diverse Cardiology Reactions

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

FDA Sounds Alarm Bells Over Use of Lariat Device for LAA Closure in A-fib Patients

Statement on LAA Closure Highlights Key Issues for Growing Field

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Study Documents Complications of LAA Closure With the Lariat Device

After Years of Scrutiny, Watchman Ready for Prime Time

Large Registry Study Suggests Amplatzer Plug Cuts Stroke, Bleeding Risks in A-fib

LAA Closure With Amplatzer Appears Safe, Effective in A-fib Patients

Time May Be Running Out for Watchman Amid Weak Support From FDA Panel

LAA Closure Edges Out Medical Therapy for Cost-effectiveness in AF

Study Indicates Snare Device for LAA Closure Should Only Be Used in Highest-Risk Patients

PREVAIL Published: Watchman, Warfarin Show Comparable Stroke Protection in A-fib

LAA Occlusion More Cost-effective Than Both Warfarin and Dabigatran for A-fib Patients

PROTECT AF: 4-Year Results Show Superiority of Watchman Over Warfarin for A-fib

ASAP Published: Watchman a Safe Option for A-fib Patients Ineligible for Warfarin

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content